Perceptive Advisors’s Agile Therapeutics AGRX Stock Holding History

Perceptive Advisors’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,647	Closed	-$158K	–	121
2022 Q3	$158K	Hold	10,647	–	–	﹤0.01%	112
2022 Q2	$620K	Hold	10,647	–	–	0.02%	104
2022 Q1	$178M	Hold	10,647	–	–	3.57%	7
2021 Q4	$10.4M	Buy	10,647 +2,687	+34%	+$3.79M	0.16%	91
2021 Q3	$15.3M	Hold	7,960	–	–	0.22%	80
2021 Q2	$21.2M	Hold	7,960	–	–	0.27%	81
2021 Q1	$33.1M	Hold	7,960	–	–	0.42%	56
2020 Q4	$45.7M	Hold	7,960	–	–	0.49%	48
2020 Q3	$48.4M	Hold	7,960	–	–	0.71%	38
2020 Q2	$44.3M	Hold	7,960	–	–	0.72%	36
2020 Q1	$29.6M	Buy	7,960 +2,000	+34%	+$11.5M	0.77%	33
2019 Q4	$29.8M	Buy	5,960 +597	+11%	+$2.08M	0.59%	39
2019 Q3	$12.7M	Buy	5,363 +1,150	+27%	+$2.83M	0.34%	52
2019 Q2	$10.4M	Hold	4,213	–	–	0.24%	63
2019 Q1	$12.7M	Buy	+4,213	New	+$8.93M	0.36%	54
2018 Q3	–	Sell	-1,765	Closed	-$1.74M	–	141
2018 Q2	$1.74M	Hold	1,765	–	–	0.05%	89
2018 Q1	$9.07M	Buy	1,765 +75	+4%	+$496K	0.25%	62
2017 Q4	$9.09M	Buy	+1,690	New	+$15.7M	0.3%	55
2017 Q2	–	Hold	0	–	–	–	166
2017 Q1	–	Sell	-331	Closed	-$1.66M	–	216
2016 Q4	$3.77M	Sell	331 -179	-35%	-$2.51M	0.27%	67
2016 Q3	$7.12M	Buy	510 +253	+98%	+$3.61M	0.46%	55
2016 Q2	$3.91M	Buy	257 +169	+192%	+$2.31M	0.27%	68
2016 Q1	$1.09M	Buy	+88	New	+$1.14M	0.1%	98

Other funds holding AGRX

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Perceptive Advisors's AGRX Position: Q4 2022 in Review

Perceptive Advisors sold out of Agile Therapeutics (AGRX) in Q4 2022, closing a stake of 10,647 shares — an estimated $158K sold.

Perceptive Advisors first reported a position in AGRX in Q1 2016 and held it in 22 quarters. The position peaked at $178M in Q1 2022. 26 funds tracked by Wall St. Rank hold AGRX as of Q4 2022.

Perceptive Advisors reported no remaining Agile Therapeutics position as of Q4 2022 after selling out during the quarter.
Perceptive Advisors sold 10,647 Agile Therapeutics shares in Q4 2022, an estimated $158K.
Perceptive Advisors first reported a position in Agile Therapeutics in Q1 2016 and held it in 22 quarters.
Perceptive Advisors's Agile Therapeutics position peaked at $178M in Q1 2022.
26 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2022.

Based on Perceptive Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.